SRTA Strata Critical Medical, Inc.
Transportation Services · Nasdaq · SEC CIK 1779128 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY68.4%
TTM net income YoY-161.4%
TTM EPS YoY-160.0%
Revenue 3-yr CAGR9.2%
Net income 3-yr CAGR—
Margins
Gross margin21.6%
Operating margin-6.6%
Net margin-8.8%
FCF margin0.3%
EBITDA margin-3.2%
Returns
ROE-8.9%
ROA-7.5%
ROIC (approx.)-5.9%
Asset turnover0.85x
Leverage & solvency
Liabilities / assets16.0%
Debt / equity0.00x
Current ratio2.77x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.43x
Accruals ratio-10.7%
Payout ratio—
Capex / revenue3.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $74.08M | $72.51M | $67.38M | $66.79M | $49.30M | $45.11M | $35.95M | $36.39M |
| Cost of revenue | $57.26M | $57.29M | $53.27M | $55.12M | $38.64M | $36.10M | $28.89M | $31.37M |
| Gross profit | $16.82M | $15.21M | $14.12M | $14.41M | $10.65M | $9.01M | $7.05M | $5.01M |
| SG&A expense | $15.14M | $14.00M | $15.61M | $17.92M | $15.91M | $13.29M | $12.33M | $11.72M |
| Operating income | -$3.83M | -$5.41M | -$2.97M | -$6.41M | -$5.62M | -$4.64M | -$5.68M | -$5.90M |
| Pretax income | -$7.62M | -$10.52M | $2.40M | -$5.39M | -$9.66M | -$3.41M | -$1.61M | -$7.43M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$7.62M | -$10.52M | $2.15M | -$8.83M | $57.42M | -$3.74M | -$3.49M | -$9.79M |
| EBITDA | -$2.03M | -$3.52M | $86,000 | -$3.40M | -$4.54M | -$3.77M | -$3.99M | -$4.37M |
| EPS (basic) | -0.09 | -0.12 | 0.03 | — | 0.70 | -0.05 | -0.04 | — |
| EPS (diluted) | -0.09 | -0.12 | 0.03 | — | 0.70 | -0.05 | -0.04 | — |
| Weighted avg. shares (diluted) | 88.27M | 86.21M | 90.17M | — | 82.45M | 81.30M | 79.89M | — |
| Banking | ||||||||
| Net interest income | — | — | — | — | — | $1.16M | $1.32M | $1.59M |
| Balance sheet | ||||||||
| Cash & equivalents | $35.14M | $16.32M | $58.72M | $31.23M | $22.75M | $58.75M | $34.83M | $19.65M |
| Short-term investments | $6.50M | $6.44M | $66,000 | $30.26M | $53.16M | $54.67M | $85.18M | $108.76M |
| Receivables | $42.77M | $43.41M | $39.60M | $39.96M | $37.54M | $28.17M | $22.13M | $19.82M |
| Current assets | $125.14M | $121.01M | $124.14M | $126.19M | $122.48M | $156.48M | $152.31M | $160.74M |
| PP&E, net | $39.62M | $40.70M | $40.09M | $36.44M | $38.56M | $33.70M | $32.57M | $28.46M |
| Goodwill | $101.92M | $106.95M | $88.59M | $88.21M | $84.61M | $44.25M | $42.04M | $15.54M |
| Intangibles | $58.83M | $60.01M | $46.31M | $47.50M | $49.75M | $13.58M | $13.53M | $7.96M |
| Total assets | $328.88M | $332.70M | $327.62M | $325.47M | $335.08M | $257.92M | $250.55M | $256.68M |
| Current liabilities | $45.12M | $45.78M | $20.94M | $19.79M | $27.87M | $26.31M | $21.88M | $22.73M |
| Total liabilities | $52.51M | $53.38M | $41.89M | $46.40M | $52.08M | $34.82M | $30.82M | $34.74M |
| Shareholders' equity | $276.38M | $279.32M | $285.73M | $279.07M | $283.00M | $223.10M | $219.73M | $221.94M |
| Cash flow statement | ||||||||
| Operating cash flow | $9.46M | $5.69M | $3.88M | -$8.31M | -$37.30M | -$3.06M | -$246,000 | -$1.75M |
| Capital expenditure | $400,000 | $2.49M | $5.18M | $1.85M | $2.83M | $2.23M | $2.61M | $4.58M |
| Free cash flow | $9.06M | $3.20M | -$1.29M | -$10.15M | -$40.13M | -$5.30M | -$2.86M | -$6.33M |
| Investing cash flow | $13.46M | -$43.88M | $24.73M | $18.27M | $2.40M | $28.68M | $20.41M | $3.98M |
| Financing cash flow | -$4.10M | -$4.21M | -$859,000 | -$1.74M | -$1.79M | -$1.14M | -$4.25M | -$3.87M |
| Depreciation & amortization | $1.80M | $1.89M | $3.06M | $3.01M | $1.08M | $867,000 | $1.70M | $1.53M |
| Stock-based compensation | $5.05M | $3.71M | $5.04M | $6.59M | $1.68M | $5.35M | $4.22M | $4.53M |
| Share buybacks | — | — | — | $0 | $0 | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 28 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.